P2RY12 and hepatocellular carcinoma: As clopidogrel and aspirin bind to different platelet receptors—respectively P2Y12 and cyclooxygenase-1 (Figure 2)—the combination of aspirin and clopidogrel can work synergistically and improve the course of HCC progression through distinct pharmacological effects.